Xin Wang

Xin Wang

Auto-generated profile, based on publicly available information

Xin Wang

Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Open access
PDF file
JYJing Yang
Jing Yang
HYHui Yang
Hui Yang
ZWZihui Wang
Zihui Wang
XWXin Wang
Xin Wang
YWYingkai Wang
Yingkai Wang
LLLihong Liu
Lihong Liu
What is known and objective The incidence of diabetes has been rising worldwide and is expected to increase to affect 591.9 million people by 2035 in China. Strict control of blood glucose can significantly reduce the risk of diabetic complications, but traditional interventions lack continuity, timeliness and teleonomy. The development of mobile health management has become a hot topic, as a very popular app in China, WeChat platform, has a large number of users every day. Many studies show the health management of patients with diabetes through WeChat can achieve the ideal effect. This study aims to evaluate the application of WeChat based on clinical research data, provide clinical evidence for medical staff and promote the self‐management of patients with diabetes. Methods The PubMed, EMBASE, Cochrane Library, CNKI and Wanfang database were searched to identify related reports that were published up to 9 March 2020. The quality of included studies was assessed by Cochrane Collaboration risk assessment tool. Measures of interest were mean difference (MD) and 95% confidence interval (CI). Random‐effect model was used according to the absence or presence of significant heterogeneity. Heterogeneity among trials was evaluated by I2 test. Publication bias was assessed by funnel plots. Results and discussion Thirty‐eight articles involved 2,709 controls and 2,709 patients who used WeChat were identified. Relative to the traditional group, WeChat group had a lower level in fasting plasma glucose (FPG in mmol/L; MD: 1.36, 95% CI 1.10‐1.62, P < .00001), so did 2hPG (MD: 1.91, 95% CI 1.48‐2.35, P < .00001) and HbA1C (MD: 1.07, 95% CI 0.86‐1.27, P < .00001). Self‐efficacy scale improved significantly, including diet score (MD: −1.31, 95% CI −1.77 to −0.86, P < .00001), exercise score (MD: −1.92, 95% CI −2.44 to −1.40, P < .00001), medication taking score (MD: −1.45, 95% CI: −1.94 to −0.97, P < .00001), monitoring of blood glucose score (MD: −1.17, 95% CI −1.83‐−0.51, P = .0005) and foot care score (MD: −1.71, 95% CI −2.08 to −1.34, P < .00001). Patients' understanding of the disease and satisfaction with follow‐up increased significantly, whereas the incidence of adverse reactions and complications decreased. What is new and conclusion WeChat follow‐up appears to be helpful to improve the level of blood glucose and self‐management, reduce the incidence of adverse reactions and complications, and improve the satisfaction rate of patients with type 2 diabetes. It should be noted that this meta‐analysis has limitations, such as small sample sizes and the low quality of included literature, as well as the lack of research in Western countries. Therefore, more high‐quality studies with larger samples are needed in the future to verify our results.

20 January 2021 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
XWXin Wang
Xin Wang
SWShihui Wang
Shihui Wang
XYXiaojia Yu
Xiaojia Yu
ZMZhuo Ma
Zhuo Ma
HWHuaguang Wang
Huaguang Wang
LLLihong Liu
Lihong Liu
Aims: This study aimed to assess the impact of pharmacist‐led medication therapy management (MTM) performed on ambulatory elderly patients with chronic diseases.Methods: Patients who came to a pharmacist‐led outpatient clinic between January 2016 and June 2018 were enrolled in this study. Eligible subjects received MTM services from the pharmacists at least twice a year and the clinical data of these patients were complete. Drug‐related problems (DRPs) and recommendations were evaluated using The Pharmaceutical Care Network Europe Classification for Drug related problems V8.03.Results: A total of 525 DRPs were identified during the study period. Treatment effectiveness (53.71%) was the most common DRP. The most frequently recommended intervention was changing the drug (48.76%). There were 92.38% patients accepting the interventions and 90.48% patients completely implemented. The number of drugs taken was the significant associated factor for DRPs. Postintervention data collection showed lower levels in systolic blood pressure (BP) and diastolic BP compared to the preintervention data collection. There were statistically significant changes in total cholesterol, low‐density lipoprotein cholesterol and triglycerides between the pre‐ and postintervention data collections. The average cost of medications per patient for every month decreased from 387.72 to 355.17 renminbi (P = .009).Conclusion: We confirmed that pharmacists had a valuable role to perform MTM services for ambulatory elderly patients, not only in identifying and solving the DRPs, but also in improving clinical outcomes (BP and lipid level) and cost‐saving effect.

12 June 2020 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
XWXin Wang
Xin Wang
HYHui Yang
Hui Yang
XHXiaopeng Hu
Xiaopeng Hu
WWWei Wang
Wei Wang
XYXiaojia Yu
Xiaojia Yu
LLLihong Liu
Lihong Liu
Background: Two new drugs, abiraterone and enzalutamide, had recently shown beneficial effects on survival in patients with metastatic castration-resistant prostate cancer. We systematically reviewed the efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer in real-world practice. Methods: A search from PubMed, Web of Science, Cochrane, Embase was conducted up to 6 March 2019. Available articles from conferences were searched. The endpoint was prostate-specific antigen response, overall survival, progression-free survival, number of patients with any adverse event. Results: Fourteen cohort studies involving 3469 participants were included. Pooled result showed that prostate-specific antigen response was higher for patients receiving enzalutamide than abiraterone (790 patients, odds ratio (OR) 0.47, 95% confidence interval (CI) 0.29–0.77, P = 0.003, I2=59%). Enzalutamide was significantly associated with increased adverse events rate in comparison with abiraterone (730 patients, OR 0.35, 95%CI 0.13–0.92, P = 0.03, I2=65%). There was no statistical difference between abiraterone and enzalutamide with respect to perceived cognitive impairments (1856 patients, OR 0.90, 95%CI 0.29–2.76, P = 0.85, I2=5%). Enzalutamide was significantly associated with increased fatigue risk in comparison with abiraterone (2477 patients, OR 0.46, 95%CI 0.34–0.63, P<0.00001, I2=0%). Conclusions: Our results demonstrated that enzalutamide was more efficacious than abiraterone for patients with metastatic castration-resistant prostate cancer, but was associated with a significantly elevated risk of side effects, particularly fatigue.

18 December 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
JZJun Zhao
Jun Zhao
XLXia Li
Xia Li
JYJiayi Yang
Jiayi Yang
XHXin Hao
Xin Hao
JTJunjian Tian
Junjian Tian
ZLZhigang Li
Zhigang Li
Objectives This study aims to investigate the incidence of and factors associated with irritable bowel syndrome (IBS) among resident physicians in standardised training at eight traditional Chinese medicine (TCM) hospitals in China. Design A cross-sectional survey was administered to resident physicians in their first to third years of standardised training at eight TCM hospitals. Participants and setting A total of 514 resident physicians in standardised training were included. Measures The questionnaire consisted of two sections, namely: section A collected basic information, and section B included the four-item Perceived Stress Scale (PSS-4), the Patient Health Questionnaire-4 (PHQ-4), the Pittsburgh Sleep Quality Index (PSQI) and the Rome IV criteria for IBS. Univariate and multivariate logistic regression models were constructed to assess the associations of age, sex, body mass index, stress, depression, anxiety, sleep quality and IBS. Results Of the included resident doctors, 77.2% were female, 20.4% were obese or underweight and 8.6% had symptoms consistent with a diagnosis of IBS. There were no statistically significant differences in lifestyle factors (night shift work, overtime work or working efficiency during the COVID-19 pandemic) between patients with IBS and participants without IBS (hereafter, non-IBS participants) (p=0.429, p=0.572 or p=0.464, respectively). Notably, compared with non-IBS participants, patients with IBS had significantly higher mean scores on the PSS-4 and PHQ-4 (p=0.028 and p=0.012, respectively); however, there was not a significant difference in PSQI scores between these two groups (p=0.079). Depression symptoms were significantly associated with IBS (unadjusted OR 0.498, 95% CI 0.265 to 0.935, p=0.030). Conclusion These findings suggest that IBS is common among resident physicians in standardised training. Future studies should investigate emotional distress, especially stress and depression, in the development of prevention or treatment of IBS.

9 June 2020 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
XWXin Wang
Xin Wang
JYJing Yang
Jing Yang
XYXiaojia Yu
Xiaojia Yu
ZWZihui Wang
Zihui Wang
HWHuaguang Wang
Huaguang Wang
LLLihong Liu
Lihong Liu

1 September 2020 in Thrombosis Research
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
SWShihui Wang
Shihui Wang
JYJing Yang
Jing Yang
XYXiaojia Yu
Xiaojia Yu
LLLihong Liu
Lihong Liu